Standard
Response to the Letter : Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al. / Holmegard, Haya Nicole; Nordestgaard, Børge; Jensen, Gorm B; Tybjærg-Hansen, Anne; Benn, Marianne.
I:
The Journal of clinical endocrinology and metabolism, Bind 101, Nr. 2, 02.2016, s. L22-L23.
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
Holmegard, HN
, Nordestgaard, B, Jensen, GB
, Tybjærg-Hansen, A & Benn, M 2016, '
Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al',
The Journal of clinical endocrinology and metabolism, bind 101, nr. 2, s. L22-L23.
https://doi.org/10.1210/jc.2015-4386APA
Holmegard, H. N.
, Nordestgaard, B., Jensen, G. B.
, Tybjærg-Hansen, A., & Benn, M. (2016).
Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al.
The Journal of clinical endocrinology and metabolism,
101(2), L22-L23.
https://doi.org/10.1210/jc.2015-4386Vancouver
Holmegard HN
, Nordestgaard B, Jensen GB
, Tybjærg-Hansen A, Benn M.
Response to the Letter: Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al.
The Journal of clinical endocrinology and metabolism. 2016 feb.;101(2):L22-L23.
https://doi.org/10.1210/jc.2015-4386Author
Holmegard, Haya Nicole ; Nordestgaard, Børge ; Jensen, Gorm B ; Tybjærg-Hansen, Anne ; Benn, Marianne. / Response to the Letter : Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al. I: The Journal of clinical endocrinology and metabolism. 2016 ; Bind 101, Nr. 2. s. L22-L23.
Bibtex
@article{d58e524720fe4c13b061539ba3eeec61,
title = "Response to the Letter: Response to {"}Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes{"} by Abasi A., et al",
keywords = "Brain Ischemia, Female, Gonadal Steroid Hormones, Humans, Male, Stroke, Comment, Letter",
author = "Holmegard, {Haya Nicole} and B{\o}rge Nordestgaard and Jensen, {Gorm B} and Anne Tybj{\ae}rg-Hansen and Marianne Benn",
year = "2016",
month = feb,
doi = "10.1210/jc.2015-4386",
language = "English",
volume = "101",
pages = "L22--L23",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "Oxford University Press",
number = "2",
}
RIS
TY - JOUR
T1 - Response to the Letter
T2 - Response to "Use of biomarkers to identify new drug targets and to predict risk of cardiometabolic outcomes" by Abasi A., et al
AU - Holmegard, Haya Nicole
AU - Nordestgaard, Børge
AU - Jensen, Gorm B
AU - Tybjærg-Hansen, Anne
AU - Benn, Marianne
PY - 2016/2
Y1 - 2016/2
KW - Brain Ischemia
KW - Female
KW - Gonadal Steroid Hormones
KW - Humans
KW - Male
KW - Stroke
KW - Comment
KW - Letter
U2 - 10.1210/jc.2015-4386
DO - 10.1210/jc.2015-4386
M3 - Letter
C2 - 26840110
VL - 101
SP - L22-L23
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 2
ER -
